BioNTech plans to vaccinate children between 5 and 11 years old from October

The founders of German biopharmaceuticals BioNTech, developer with the American pharmaceutical company Pfizer one of the COVID-19 vaccines, He intends to be able to administer his preparation from mid-October also to minors between 5 and 11 years old..

“Already in the coming weeks, we will present to authorities around the world the results of our study concerning minors between 5 and 11 years old and we will ask for vaccine authorization for this age group, here also in Europe ”, assured the co-founder of BioNTech, Ozlem Tureci.

In statements to Spiegel as the weekly advances today, added that production is already in preparation and the vaccine will be the same, but with a lower dosage.

Co-founder of BioNTech, Ugur Sahin, specifies that the results of the study are already on the table And they just need to be prepared now for the regulators.

Besides, By the end of the year, he should have the study data on minors from six months old..

The same time, the two founders of BioNTech called for doing their best in the coming weeks to convince the undecided the benefits of the vaccine.

“As a company, we still have about 60 days to avoid a harsh winter “ and “We must do everything during these two months to mobilize as many people as possible.said ahin.

Türeci underlined that “each additional vaccinated person helps”. “We must not resign ourselves,” he said.

The German Standing Immunization Commission (Stiko) has generally recommended the COVID-19 vaccine from the age of 12 in mid-August. Until then, the Stiko only recommended vaccinating minors from 12 years old with previous illnesses and generally for adolescents from 16 years old.

Until Thursday, 35.9% of minors between 12 and 17 years old had been vaccinated, 24.7% with the complete diet. As, 83.3% of citizens over 60 and 66.9% of adults between 18 and 59 have the full guideline. Yes indeed, 66.3% of the population was vaccinated, 61.9% with the complete regimen.

Health authorities have verified 12,969 new infections in 24 hours and 55 deaths from or with COVID-19, while active cases in Germany are around 156,500, according to data from the Robert Koch Institute (RKI) updated yesterday morning.

The cumulative incidence in seven days is 83.8 new infections with the coronavirus per 100,000 inhabitants.

The RKI reported in its daily report 520 hospitalizations COVID-19 patients in one day, bringing the admission rate to 1.95 per 100,000 population.

Percentage of COVID-19 patients admitted to intensive care units stands at 6.2 percent.

(With information from EFE)

Read on: